Full details of fusion biopsy technique: casit.ucla.edu A new research study at UCLA aims to re-define prostate cancer significance through clinical validation of a tool which allows 3D visualization and tracking of the prostate. By fusing multi-parametric MRI (T2-weighted, diffusion-weighted imaging, dynamic contrast enhancement) with real-time ultrasound, suspicious areas seen on the MRI can be tracked and targeted during prostate biopsy. This research aims to improve currently available methods of cancer diagnosis. Investigators: Leonard Marks, MD (Urology, usrf.org Daniel Margolis, MD (Radiology, www.radnet.ucla.edu Jiaoti Huang, MD, Ph.D. (Pathology, faculty.pathology.ucla.edu
Keywords: prostate, cancer, fusion, biopsy, ultrasound, health, UCLA, Urology, CASIT, mri, targeted, 3D, Artemis, diffusion, weighted, dynamic, contrast, enhancement, multi-parametric, MR, multi-modal
No comments:
Post a Comment